RIO DE JANEIRO, BRAZIL - The Coronavac vaccine has proven to be both effective and safe, according to a study released this week by Chinese pharmaceutical company Sinovac Life Science. The study analyzed the behavior of 600 immunized volunteers in China during phase 2 clinical trials. The vaccine is developed by Sinovac Life Science in partnership with the Butantan Institute in São Paulo.
According to the Coronavac vaccine clinical trials coordinator and the Butantan Institute Medical Director of Clinical Research, Ricardo Palácios, the product is very promising and effective. "The studies conducted thus far in China have shown that . . .